| Emily Ann Chandler, FNP | |
|
10 E 13th St, Grove, OK 74344-5300 | |
| (918) 786-1909 | |
| (918) 787-3866 |
| Full Name | Emily Ann Chandler |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 10 E 13th St, Grove, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275020943 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 97251 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Integris Grove Hospital | Grove, OK | Hospital |
| Cherokee Nation W W Hastings Indian Hospital | Tahlequah, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ahs Oklahoma Heart Llc | 4587737135 | 109 |
News Archive
Teens and young adults who are exposed to marketing materials for tobacco products, such as coupons and websites, were far more likely to begin smoking or to be current smokers than those not exposed, finds a new study in the Journal of Adolescent Health.
American Medical Systems, a leading provider of world-class devices and therapies for both male and female pelvic health, announced today that the United States Patent and Trademark Office has issued U.S. Patent Number 7,686,760 covering the surgical methodology for implanting the AMS AdVance® Male Sling. This patent provides AMS with broad patent coverage on transobturator surgical procedures to treat male incontinence.
Democratic vice presidential nominee Sen. Joseph Biden (Del.) on Tuesday during a campaign event in Mehlville, Mo., said that Republican presidential nominee Sen. John McCain (Ariz.) as president would place employer-sponsored health insurance at risk, the St. Louis Post-Dispatch reports.
Depression in older adults may be linked to memory problems, according to a study published in the May 9, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
Trubion Pharmaceuticals, Inc. today announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in Phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the companies' CD20 collaboration. However, Pfizer has confirmed that it will continue to develop SBI-087 (PF-05230895), Trubion's next-generation, humanized, subcutaneous CD20 RA product candidate also in Phase 2 clinical evaluation.
› Verified 8 days ago
| Entity Name | Integris Miami Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912508375 PECOS PAC ID: 1254235468 Enrollment ID: O20031120000383 |
News Archive
Teens and young adults who are exposed to marketing materials for tobacco products, such as coupons and websites, were far more likely to begin smoking or to be current smokers than those not exposed, finds a new study in the Journal of Adolescent Health.
American Medical Systems, a leading provider of world-class devices and therapies for both male and female pelvic health, announced today that the United States Patent and Trademark Office has issued U.S. Patent Number 7,686,760 covering the surgical methodology for implanting the AMS AdVance® Male Sling. This patent provides AMS with broad patent coverage on transobturator surgical procedures to treat male incontinence.
Democratic vice presidential nominee Sen. Joseph Biden (Del.) on Tuesday during a campaign event in Mehlville, Mo., said that Republican presidential nominee Sen. John McCain (Ariz.) as president would place employer-sponsored health insurance at risk, the St. Louis Post-Dispatch reports.
Depression in older adults may be linked to memory problems, according to a study published in the May 9, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
Trubion Pharmaceuticals, Inc. today announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in Phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the companies' CD20 collaboration. However, Pfizer has confirmed that it will continue to develop SBI-087 (PF-05230895), Trubion's next-generation, humanized, subcutaneous CD20 RA product candidate also in Phase 2 clinical evaluation.
› Verified 8 days ago
| Entity Name | Integris Grove Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134720592 PECOS PAC ID: 0042105835 Enrollment ID: O20040219000842 |
News Archive
Teens and young adults who are exposed to marketing materials for tobacco products, such as coupons and websites, were far more likely to begin smoking or to be current smokers than those not exposed, finds a new study in the Journal of Adolescent Health.
American Medical Systems, a leading provider of world-class devices and therapies for both male and female pelvic health, announced today that the United States Patent and Trademark Office has issued U.S. Patent Number 7,686,760 covering the surgical methodology for implanting the AMS AdVance® Male Sling. This patent provides AMS with broad patent coverage on transobturator surgical procedures to treat male incontinence.
Democratic vice presidential nominee Sen. Joseph Biden (Del.) on Tuesday during a campaign event in Mehlville, Mo., said that Republican presidential nominee Sen. John McCain (Ariz.) as president would place employer-sponsored health insurance at risk, the St. Louis Post-Dispatch reports.
Depression in older adults may be linked to memory problems, according to a study published in the May 9, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
Trubion Pharmaceuticals, Inc. today announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in Phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the companies' CD20 collaboration. However, Pfizer has confirmed that it will continue to develop SBI-087 (PF-05230895), Trubion's next-generation, humanized, subcutaneous CD20 RA product candidate also in Phase 2 clinical evaluation.
› Verified 8 days ago
| Entity Name | Integris Ambulatory Care Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750333936 PECOS PAC ID: 2365408465 Enrollment ID: O20041209000354 |
News Archive
Teens and young adults who are exposed to marketing materials for tobacco products, such as coupons and websites, were far more likely to begin smoking or to be current smokers than those not exposed, finds a new study in the Journal of Adolescent Health.
American Medical Systems, a leading provider of world-class devices and therapies for both male and female pelvic health, announced today that the United States Patent and Trademark Office has issued U.S. Patent Number 7,686,760 covering the surgical methodology for implanting the AMS AdVance® Male Sling. This patent provides AMS with broad patent coverage on transobturator surgical procedures to treat male incontinence.
Democratic vice presidential nominee Sen. Joseph Biden (Del.) on Tuesday during a campaign event in Mehlville, Mo., said that Republican presidential nominee Sen. John McCain (Ariz.) as president would place employer-sponsored health insurance at risk, the St. Louis Post-Dispatch reports.
Depression in older adults may be linked to memory problems, according to a study published in the May 9, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
Trubion Pharmaceuticals, Inc. today announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in Phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the companies' CD20 collaboration. However, Pfizer has confirmed that it will continue to develop SBI-087 (PF-05230895), Trubion's next-generation, humanized, subcutaneous CD20 RA product candidate also in Phase 2 clinical evaluation.
› Verified 8 days ago
| Entity Name | Ahs Oklahoma Heart Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780857540 PECOS PAC ID: 4587737135 Enrollment ID: O20080716000032 |
News Archive
Teens and young adults who are exposed to marketing materials for tobacco products, such as coupons and websites, were far more likely to begin smoking or to be current smokers than those not exposed, finds a new study in the Journal of Adolescent Health.
American Medical Systems, a leading provider of world-class devices and therapies for both male and female pelvic health, announced today that the United States Patent and Trademark Office has issued U.S. Patent Number 7,686,760 covering the surgical methodology for implanting the AMS AdVance® Male Sling. This patent provides AMS with broad patent coverage on transobturator surgical procedures to treat male incontinence.
Democratic vice presidential nominee Sen. Joseph Biden (Del.) on Tuesday during a campaign event in Mehlville, Mo., said that Republican presidential nominee Sen. John McCain (Ariz.) as president would place employer-sponsored health insurance at risk, the St. Louis Post-Dispatch reports.
Depression in older adults may be linked to memory problems, according to a study published in the May 9, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
Trubion Pharmaceuticals, Inc. today announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in Phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the companies' CD20 collaboration. However, Pfizer has confirmed that it will continue to develop SBI-087 (PF-05230895), Trubion's next-generation, humanized, subcutaneous CD20 RA product candidate also in Phase 2 clinical evaluation.
› Verified 8 days ago
| Entity Name | Rapid Remedy Urgent Care Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558592352 PECOS PAC ID: 5092861385 Enrollment ID: O20090929000470 |
News Archive
Teens and young adults who are exposed to marketing materials for tobacco products, such as coupons and websites, were far more likely to begin smoking or to be current smokers than those not exposed, finds a new study in the Journal of Adolescent Health.
American Medical Systems, a leading provider of world-class devices and therapies for both male and female pelvic health, announced today that the United States Patent and Trademark Office has issued U.S. Patent Number 7,686,760 covering the surgical methodology for implanting the AMS AdVance® Male Sling. This patent provides AMS with broad patent coverage on transobturator surgical procedures to treat male incontinence.
Democratic vice presidential nominee Sen. Joseph Biden (Del.) on Tuesday during a campaign event in Mehlville, Mo., said that Republican presidential nominee Sen. John McCain (Ariz.) as president would place employer-sponsored health insurance at risk, the St. Louis Post-Dispatch reports.
Depression in older adults may be linked to memory problems, according to a study published in the May 9, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
Trubion Pharmaceuticals, Inc. today announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in Phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the companies' CD20 collaboration. However, Pfizer has confirmed that it will continue to develop SBI-087 (PF-05230895), Trubion's next-generation, humanized, subcutaneous CD20 RA product candidate also in Phase 2 clinical evaluation.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Ann Chandler, FNP 5300 N Independence Ave Ste 280, Oklahoma City, OK 73112-5555 Ph: (918) 786-1909 | Emily Ann Chandler, FNP 10 E 13th St, Grove, OK 74344-5300 Ph: (918) 786-1909 |
News Archive
Teens and young adults who are exposed to marketing materials for tobacco products, such as coupons and websites, were far more likely to begin smoking or to be current smokers than those not exposed, finds a new study in the Journal of Adolescent Health.
American Medical Systems, a leading provider of world-class devices and therapies for both male and female pelvic health, announced today that the United States Patent and Trademark Office has issued U.S. Patent Number 7,686,760 covering the surgical methodology for implanting the AMS AdVance® Male Sling. This patent provides AMS with broad patent coverage on transobturator surgical procedures to treat male incontinence.
Democratic vice presidential nominee Sen. Joseph Biden (Del.) on Tuesday during a campaign event in Mehlville, Mo., said that Republican presidential nominee Sen. John McCain (Ariz.) as president would place employer-sponsored health insurance at risk, the St. Louis Post-Dispatch reports.
Depression in older adults may be linked to memory problems, according to a study published in the May 9, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.
Trubion Pharmaceuticals, Inc. today announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in Phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the companies' CD20 collaboration. However, Pfizer has confirmed that it will continue to develop SBI-087 (PF-05230895), Trubion's next-generation, humanized, subcutaneous CD20 RA product candidate also in Phase 2 clinical evaluation.
› Verified 8 days ago
Ms. Dorothy Ann Mayes, ARNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1121 Neo Loop, Grove, OK 74344 Phone: 918-786-8448 Fax: 918-786-3483 | |
Christopher Gray, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10 E 13th St, Grove, OK 74344 Phone: 918-786-1909 | |
Amber Davis, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 900 E 13th St Ste 200, Grove, OK 74344 Phone: 918-592-0999 | |
Joseph James Gelinas, APRN-CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 601 S Broadway St, Grove, OK 74344 Phone: 918-786-0800 Fax: 918-786-0876 | |
Shealyn Berry, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 601 E 13th St Ste Acgh, Grove, OK 74344 Phone: 918-786-9009 | |
Deborah L Hendrix, ARNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4602 Highway 59 N, Grove, OK 74344 Phone: 918-786-5026 |